These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24699624)

  • 61. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
    Kalechman Y; Sredni B
    J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.
    Kalechman Y; Barkai IS; Albeck M; Horwith G; Sehagl SN; Sredni B
    Cancer Res; 1991 Oct; 51(20):5614-20. PubMed ID: 1913679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
    Deng X; Kornblau SM; Ruvolo PP; May WS
    J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
    Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.
    Cho C; Horzempa C; Jones D; McKeown-Longo PJ
    BMC Cancer; 2016 Aug; 16():574. PubMed ID: 27484721
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
    Tabe Y; Jin L; Tsutsumi-Ishii Y; Xu Y; McQueen T; Priebe W; Mills GB; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
    Cancer Res; 2007 Jan; 67(2):684-94. PubMed ID: 17234779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: a role for the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-5.
    Messinger Y; Chelstrom L; Gunther R; Uckun FM
    Leuk Lymphoma; 1996 Sep; 23(1-2):61-9. PubMed ID: 9021687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
    Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
    Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
    Ahmed N; Laverick L; Sammons J; Zhang H; Maslin DJ; Hassan HT
    Anticancer Res; 2001; 21(5):3519-23. PubMed ID: 11848518
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
    Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of the novel tellurium compound AS101 on autoimmune diseases.
    Halpert G; Sredni B
    Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
    Wang H; Zhang D; Cui X; Dai Y; Wang C; Feng W; Lv X; Li Y; Wang L; Ru Y; Zhang Y; Ren Q; Zheng G
    Oncogene; 2022 Apr; 41(16):2303-2314. PubMed ID: 35256780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.
    Sredni B; Albeck M; Kazimirsky G; Shalit F
    Int J Immunopharmacol; 1992 May; 14(4):613-9. PubMed ID: 1521929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways.
    Minařík L; Pimková K; Kokavec J; Schaffartziková A; Vellieux F; Kulvait V; Daumová L; Dusilková N; Jonášová A; Vargová KS; Králová Viziová P; Sedláček R; Zemanová Z; Stopka T
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunomodulating tellurium compounds as anti-cancer agents.
    Sredni B
    Semin Cancer Biol; 2012 Feb; 22(1):60-9. PubMed ID: 22202556
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.
    Chiaverini L; Cirri D; Tolbatov I; Corsi F; Piano I; Marrone A; Pratesi A; Marzo T; La Mendola D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.